Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leiomyosarcoma × olaparib × Clear all

Sponsor

Conditions

Ovarian Neoplasms 22 Breast Neoplasms 11 Prostatic Neoplasms 10 Triple Negative Breast Neoplasms 7 Fallopian Tube Neoplasms 7 Neoplasm Metastasis 5 Stomach Neoplasms 4 Sarcoma 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Metastatic Castration-resistant Prostate Cancer 4 Fanconi Anemia, Complementation Group D1 4 Small Cell Lung Carcinoma 3 Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Wilms Tumor 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioma 2 Ependymoma 2 Endometrial Neoplasms 2

Interventions

Doxorubicin 6 pazopanib 5 Gemcitabine 4 pembrolizumab 3 Trabectedin 3 Sorafenib 3 Docetaxel 3 Dacarbazine 3 eribulin 2 Sunitinib 2 Radiotherapy, Conformal 2 Radiotherapy 2 Nivolumab 2 Letrozole 2 Ifosfamide 2 Bevacizumab 2 tremelimumab 1 temsirolimus 1 saracatinib 1 sapanisertib 1 rucaparib 1 romidepsin 1 olaratumab 1 mocetinostat 1 liposomal doxorubicin 1 lenvatinib 1 indolepropanol phosphate 1 durvalumab 1 cixutumumab 1 berzosertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡